FOGC News Tuesday, July 1, 2014 11:39:19 PM $FOGC

FOGC News Tuesday, July 1, 2014 11:39:19 PM $FOGC

Fortune Oil and Gas announces name change and plans to improve share structure
PR Newswire - Mon Jun 30, 8:45AM CDT
Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.

Manzo Pharmaceuticals announces the release of its newest product Tummy Relief a natural colic remedy for babies
PR Newswire - Tue Jun 17, 3:02PM CDT
Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that its wholly owned subsidiary, Manzo Pharmaceuticals has released its first retail product to be available to the public. It is a remedy for babies with excess gas, which often causes a condition known as colic. The product, called Manzo's Tummy Relief, is currently available for purchase on Amazon.com.

Manzo Pharmaceuticals starts laboratory testing of its lactose intolerance probiotic treatment
PR Newswire - Mon Jun 16, 7:00AM CDT
Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company's wholly owned subsidiary, Manzo Pharmaceuticals has begun a series of laboratory testing for its patented probiotic formula, Lacto-Freedom(TM). Lacto-Freedom(TM) is designed to stop the symptoms of lactose intolerance for up to several months after taking it for just a short time. The company started a six month long study with different dosages of the probiotic to find the optimum amount needed to achieve the desired effect. The safety of the product will also be confirmed over the course of this study and will prepare the product for human clinical trials. A stability test may also be performed to determine the best way to store the product and which dosage form is best (liquid, capsule, freeze dried powder, or pre-mixed in food) this study will bring Manzo Pharmaceuticals one-step closer to making this unique treatment available to the people who need it.

Fortune Oil & Gas announces major change in business direction with the acquisition of Manzo Pharmaceuticals
PR Newswire - Wed Jun 11, 3:01PM CDT
Fortune Oil & Gas, Inc. (OTCPink: FOGC), today announced that the company has acquired Manzo Pharmaceuticals, LLC., a private firm aiming to become a major force in the pharmaceutical industry. As part of the acquisition, Manzo Pharmaceutical's founder and President, Kenneth Manzo has been appointed CEO and Chairman of Fortune Oil & Gas, Inc.

TheStock411.com Issues Investment Alert On (PINKSHEETS: FOGC), (PINKSHEETS: BGOI), (NYSEAMEX: VRNG), (OTC: GSPT), (OTC: BGNN)
M2 - Tue Jan 29, 9:27AM CST
TheStock411.com Is announcing Investment Highlights on FORTUNE OIL & GAS INC(PINKSHEETS: FOGC), Bonanza Oil & Gas Inc(PINKSHEETS: BGOI), Vringo Inc (NYSEAMEX: VRNG), TERRALENE FUELS (OTC: GSPT)

Kabe Exploration Inc. Announces Fortune as Operator of Kansas Mississippian Lime Acreage for Oil Development
Business Wire - Wed Jan 16, 4:00AM CST
Kabe Exploration Inc. (OTCBB: KABX) today announced that Fortune Oil & Gas Ltd. has agreed to be the operator for the Horizontal Mississippian Lime Oil Development in Cowley County, Kansas. Fortune (based in Willis, Texas) is a registered operator in Kansas, Texas and Louisiana. Fortune will be engaged in the upstream activities of developing and operating production for Kabe in a proposed development of up to 50 horizontal oil wells in the Mississippian Lime Oil Development.